摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-3-[3-[(2,2-dichloroacetyl)amino]-4-[2-(diethylamino)ethylsulfanyl]phenyl]-N-hydroxyprop-2-enamide

中文名称
——
中文别名
——
英文名称
(E)-3-[3-[(2,2-dichloroacetyl)amino]-4-[2-(diethylamino)ethylsulfanyl]phenyl]-N-hydroxyprop-2-enamide
英文别名
——
(E)-3-[3-[(2,2-dichloroacetyl)amino]-4-[2-(diethylamino)ethylsulfanyl]phenyl]-N-hydroxyprop-2-enamide化学式
CAS
——
化学式
C17H23Cl2N3O3S
mdl
——
分子量
420.4
InChiKey
FDYCCWDPHWOAPH-SOFGYWHQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    26
  • 可旋转键数:
    10
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    107
  • 氢给体数:
    3
  • 氢受体数:
    5

文献信息

  • NOVEL HISTONE DEACETYLASE INHIBITORS, PROCESS FOR PREPARATION AND USES THEREOF
    申请人:Yu Niefang
    公开号:US20110218221A1
    公开(公告)日:2011-09-08
    The present invention relates to compounds represented by formula (I) or composition comprising at least one of such compounds, which are inhibitors of histone deacetylase. The detailed description of these compounds is disclosed in the Description. These compounds and the composition comprising the same may be useful as medicaments for the treatment of proliferative disorders as well as other diseases involving, relating to or associated with enzymes having histone deacetylase (HDAC) activities.
    本发明涉及化学式(I)所代表的化合物或含有这些化合物中至少一种的组合物,这些化合物是组蛋白去乙酰化酶抑制剂。这些化合物的详细描述在说明书中公开。这些化合物和含有它们的组合物可能作为药物用于治疗增生性疾病以及涉及、与或相关的组蛋白去乙酰化酶(HDAC)活性的其他疾病。
  • HISTONE DEACETYLASE INHIBITOR, COMPOSITION AND USE THEREOF
    申请人:Zhejiang Hisun Pharmaceutical Co. Ltd.
    公开号:EP2208721A1
    公开(公告)日:2010-07-21
    The present invention relates to compounds represented by formula (I) or composition comprising at least one of such compounds, which are inhibitors of histone deacetylase. The detailed description of these compounds is disclosed in the Description. These compounds and the composition comprising the same may be useful as medicaments for the treatment of proliferative disorders as well as other diseases involving, relating to or associated with enzymes having histone deacetylase (HDAC) activities.
    本发明涉及式(I)代表的化合物或包含至少一种此类化合物的组合物,它们是组蛋白去乙酰化酶抑制剂。这些化合物的详细描述见说明书。这些化合物和包含这些化合物的组合物可用作治疗增殖性疾病以及其他涉及、与具有组蛋白去乙酰化酶(HDAC)活性的酶有关或相关的疾病的药物。
  • US8921424B2
    申请人:——
    公开号:US8921424B2
    公开(公告)日:2014-12-30
查看更多